Supporting Quality Care: Managing Diabetes

October 29, 2021

More than 34 million Americans – just over one in 10 – have diabetes, according to the Centers for Disease Control and Prevention  (CDC). Because symptoms can develop slowly, one in five don’t know they have it. We encourage providers to talk with our members about diabetes,  including:

Why Diabetes Care Is Important
If left unmanaged, diabetes can lead to serious complications. These may include heart disease, stroke, hypertension, blindness, kidney disease, diseases of the nervous system, amputations and premature death. Providers play an important role in supporting our members through regular screenings, tests and office visits. See our preventive care and clinical practice guidelines on diabetes, and tools from the CDC .

Closing Care Gaps
As part of monitoring and helping improve quality of care, we track Comprehensive Diabetes Care (CDC) . CDC is a Healthcare Effectiveness Data and Information Set (HEDIS®) measure from the National Committee for Quality Assurance (NCQA). The measurement tracks our members, ages 18 to 75 years old with diabetes (type 1 or type 2), who had each of the following completed during the measurement year:

  • Hemoglobin A1c (HbA1c) testing
  • HbA1c poor control (>9.0%)
  • HbA1c control (<8.0%)
  • Retinal eye exam
  • Medical attention for nephropathy
  • Blood pressure control (<140/90 mm Hg)

In addition to CDC, we track Kidney Health Evaluation for Patients with Diabetes (KED).  This is a HEDIS measure developed by NCQA with input from the National Kidney Foundation. It applies to our members ages 18 to 85 years old with diabetes (type 1 or type 2) who received a kidney health evaluation. An evaluation is defined by an estimated glomerular filtration rate (eGFR)* and a urine albumin-creatinine ratio (uACR) during the measurement year.

Tips to Consider

  • Identify care gaps and schedule lab tests before office visits to review results and adjust treatment plans if needed.
  • Complete urine protein testing for attention to nephropathy at any office visit. Testing includes basic urinalysis by dip stick or tablet reagent.
  • Document medication adherence to angiotensin-converting enzyme (ACE) inhibitors and angiotensin II receptor blockers (ARB) when applicable.
  • Repeat abnormal lab tests later in the year to document improvement.
  • Monitor blood pressure status at each visit and adjust medications as needed for control.
  • Encourage members with diabetes to have annual retinal eye exams by an eye care specialist.
  • Communicate with members and other treating providers to ensure all tests are completed and results are documented in the medical record.

*BCBSIL’s Medical Policy SUR703.007, Kidney Transplant, was updated recently with the following note: Per a joint statement by the National Kidney Foundation (NKF) and the American Society of Nephrology (ASN), race modifiers should not be included in equations to estimate kidney function

The above material is for informational purposes only and is not a substitute for the independent medical judgment of a physician or other health care provider. Physicians and other health care providers are encouraged to use their own medical judgment based upon all available information and the condition of the patient in determining the appropriate course of treatment. The fact that a service or treatment is described in this material is not a guarantee that the service or treatment is a covered benefit and members should refer to their certificate of coverage for more details, including benefits, limitations and exclusions. Regardless of benefits, the final decision about any service or treatment is between the member and their health care provider.

HEDIS is a registered trademark of NCQA. Use of this resource is subject to NCQA’s copyright,